Medtronic to acquire Contego Medical for $380 million
MDT•Medtronic plans to acquire privately held Contego Medical for $380 million, with potential post-acquisition payments. The deal is expected to close in the third quarter of Medtronic’s fiscal year and minimally dilute adjusted EPS in FY27 and FY28 before becoming neutral to accretive thereafter.
1. Deal details
Medtronic plans to acquire Contego Medical for $380 million, with potential post-acquisition payments. Closing is expected in the third quarter of Medtronic’s fiscal year, subject to customary conditions.
2. Portfolio expansion
The acquisition would add Contego’s Neuroguard IEP Direct System to Medtronic’s carotid treatment portfolio and bring in its Excipio peripheral thrombectomy devices. Medtronic said the deal is expected to minimally dilute adjusted EPS in FY27 and FY28, becoming neutral to accretive thereafter. It builds on an exclusive U.S. distribution agreement first announced in January 2025.




